|
STX7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.067600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.008200E-01 |
| Normal-vs-Stage2 |
5.816400E-02 |
| Normal-vs-Stage3 |
5.488000E-01 |
| Normal-vs-Stage4 |
9.835000E-01 |
| Stage1-vs-Stage2 |
1.009240E-01 |
| Stage1-vs-Stage3 |
4.257000E-01 |
| Stage1-vs-Stage4 |
9.447400E-01 |
| Stage2-vs-Stage3 |
4.471200E-01 |
| Stage2-vs-Stage4 |
2.674600E-01 |
| Stage3-vs-Stage4 |
7.184200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.029600E-01 |
| Normal-vs-AfricanAmerican |
3.341600E-01 |
| Normal-vs-Asian |
9.115200E-01 |
| Caucasian-vs-AfricanAmerican |
5.018800E-01 |
| Caucasian-vs-Asian |
9.479000E-01 |
| AfricanAmerican-vs-Asian |
9.623400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.360800E-01 |
| Normal-vs-Female |
4.529200E-01 |
| Male-vs-Female |
6.504400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.817600E-01 |
| Normal-vs-Extreme_Weight |
1.899800E-01 |
| Normal-vs-Obese |
2.031800E-01 |
| Normal-vs-Extreme_Obese |
3.724400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.012200E-01 |
| Normal_Weight-vs-Obese |
1.930000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.463400E-01 |
| Extreme_Weight-vs-Obese |
3.564400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.263610E-01 |
| Obese-vs-Extreme_Obese |
9.506200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.216600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.816200E-02 |
| Normal-vs-Age(61-80Yrs) |
6.365000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.775000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.413800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.155200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.154600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.413500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.913000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.355400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.766000E-01 |
| Normal-VS-Type2 PRCC |
1.734570E-01 |
| Normal-VS-KIRP CIMP |
8.360600E-03 |
| Normal-VS-Unclassified PRCC |
3.264000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.234600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.803700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.776400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.601300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.747600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.993900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.969200E-01 |
| Normal-vs-N1 |
9.231200E-01 |
| Normal-vs-N2 |
4.823100E-04 |
| N0-vs-N1 |
9.290600E-01 |
| N0-vs-N2 |
1.189560E-01 |
| N1-vs-N2 |
9.973800E-02 |
|
|
